• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Duke University

Nanotech, immunotherapy combo vaccinates mouse against cancer

August 18, 2017 By Sarah Faulkner

Nanostar

Researchers from Duke University combined an FDA-approved cancer immunotherapy with gold nanostars to boost the cancer-killing abilities of both therapies, according to a study published this week in Scientific Reports. The combination therapy cured two mice and vaccinated one against bladder cancer, the team reported. “The ideal cancer treatment is non-invasive, safe and uses multiple approaches,” […]

Filed Under: Featured, Oncology, Pharmaceuticals, Research & Development Tagged With: Duke University

Biopolymer tested as long-acting glucose control therapy

June 6, 2017 By Sarah Faulkner

Researchers from Duke University have developed a biopolymer that could provide weeks of glucose control for patients with diabetes – in a single injection. The controlled-release treatment lasted for weeks in primates, according to a study published in Nature Biomedical Engineering. The biomedical engineers suggested that this new, injectable solution could replace daily or weekly insulin shots for […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Preclinical Trials, Research & Development Tagged With: Duke University

Homing system targets drugs to specific neurons

April 7, 2017 By Sarah Faulkner

Homing system targets drugs to specific neurons

Researchers from Duke University and the Howard Hughes Medical Institute have developed a technique to target and deliver drugs to specific types of neurons in the brain. The team argues that this will enable scientists to more accurately study neurological disease while offering a more targeted treatment method. The current method of treatment for neurological […]

Filed Under: Featured, Neurological, Research & Development Tagged With: Duke University

Valerion develops antibody delivery method for Pompe disease therapy

March 3, 2017 By Sarah Faulkner

Valerion develops antibody delivery method for Pompe disease therapy

Valerion Therapeutics said today that the company developed a fusion protein, VAL-1221, that combines its antibody delivery system with recombinant human acid alpha-glucosidase (rhGAA) to better deliver rhGAA into affected tissues of patients with Pompe disease. Patients who suffer from Pompe disease have a deficient supply of the lysosomal enzyme, GAA, which causes glycogen to […]

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: Duke University, Valerion Therapeutics

Modification to delivery polymer sidesteps allergic response

December 1, 2016 By Sarah Faulkner

Researchers from Duke University have reconfigured the popular drug-delivery polymer, polyethylene glycol, to sidestep dangerous immune responses that have previously halted clinical trials. The team’s work was published in Nature Biomedical Engineering. Polyethylene glycol, PEG, is a polymer that is found in toothpaste and cosmetics, but is often used in pharmaceuticals. It can be attached to […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Duke University

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS